维普中文期刊产品整合服务
58篇 您的检索式:作者名="Halank M"
    题名 作者 年代 出处 被引量
1Fingolimod in a patient with heart failure on the background of pulmonary arterial hyperten- sion and coronary artery disease显示文摘Thomas K Schrotter H Halank M 2014BMC Neurol2014,14,:1
2Portopulmonary hypertension 显示文摘Halank M Ewart R Seyfarth H J 2006J Gastroentero12006,41,9:1
3Monotherapy versus combination therapy in patients hospitalized with community-acquired pneumonia显示文摘 Halank M Hffken G 2006Treat Respir Med2006,5,:1
4Rio- ciguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase Ⅱ study显示文摘GHOFRANI H A HOEPER M M HALANK M 2010Eur Respir J2010,36,4:1
5Bosentan therapy for portopulmonary hypertension显示文摘Hoeper MM Halank M Marx C 2005Eur Respir J2005,25,3:1
6Riociguat for chro- nic thromboembolic pulmonary hypertension and pulmonary arteri- al hypertension: a phase II study显示文摘Ghofrani HA Hoeper MM Halank M 2010Eur Respir J2010,36,4:1
7Portopulmonary hypertension显示文摘Halank M Ewert R Seyfarth HS 2006J Gastroenterol2006,41,9:1
8Portopulmonary hypertension显示文摘 Ewert R Seyfarth HJ 2006J Gastroanterol2006,41,:1
9Rioeiguat for intersti- tial lung disease and pulmonary hypertension: a pilot trial显示文摘Hoeper MM Halank M Wilkens H 2013Eur Respir J2013,41,4:1
10Inhalative iloprost- pharmacology and clinical application显示文摘Ewert R Schitper C Halank M 2009Expert Opin Pharmacother2009,10,13:1
11Portopulmonary hypertension显示文摘 Ewert R Seyfarth HJ 2006J Gastrcenterol2006,41,:1
12Hemoptysis because of pulmonary vein stenosis and occlusion after pulmonary vein isolation for atrial fibrillation 显示文摘Braun S Kolditz M Halank M 2011Dtsch Med Wochens- chr2011,136,13:1
13Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension显示文摘Hoeper M Leuchte H Halank M 2006Eur Respir J2006,28,4:1
14Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study显示文摘Ghofrani HA Hoeper MM Halank M 2010Eur RespirJ2010,36,4:1
15Copeptin predicts clinical deterioration and persistent instability in community - acquired pneumonia 显示文摘KOLDITZ M HALANK M SCHULTE HUBBERT B 2012Rcspir Med2012,106,9:1
16Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension:a phase II study显示文摘Ghofrani HA Hoeper MM Halank M 2010Eur Respir J2010,36,4:1
17Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia 显示文摘Kolditz M Halank M Schulte-Hubbert B 2012Respir Med2012,106,9:1
18High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions 显示文摘Kolditz M Halank M Sehiemanck CS 2006Eur Respir J2006,28,1:1
19Intimal pulmonary artery sarcoma presenting as severe dyspnea and right heart insufficiency显示文摘Halank M Jakob C Kolditz M 2010Onkologie2010,33,6:1
20Inhalative iloprost-pharmacology and clinical application 显示文摘Ewert R Schaper C Halank M 2009Expert OpinPharmacother2009,10,13:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费